Additionally, PTPN22 was overexpressed in CLL patients and PTPN22 overexpression inhibited antigen-induced apoptosis of CLL cells (Negro et al., 2012). This evidence concerns the gene PTPN22 and B-cell chronic lymphocytic leukemia.